Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Meet the team
 
Shawn Schmitt

Shawn M. Schmitt

US

Shawn.Schmitt@informa.com

@MedtechShawn

Executive Editor Shawn M. Schmitt lives and works in Miami. Since 2005 he has reported on medical device regulation, policy, quality control, compliance, enforcement and postmarket issues. For more than two decades Shawn has written and edited for high-profile media outlets, including The New Republic and London's Independent Television News (ITN). He reported from the White House for Counseling Today, met with medical device experts in Costa Rica for Medtech Insight, traveled the US to get the scoop on Medicare funding for DecisionHealth, and wrote about nuclear proliferation for National Journal's Global Security Newswire. Shawn holds a Master of Arts in Communication: Journalism and Public Affairs from American University in Washington, DC, and a Bachelor of Arts in Journalism and Communications from Point Park University in Pittsburgh.

Read more »


Reed Miller

US

Reed.Miller@informa.com

@MedtechReed

Reed focuses on new technology development, especially the conduct and regulation of clinical trials of cardiovascular devices. He also contributes to Medtech Insight's commercial coverage, ranging from the newest start-ups to the largest established conglomerates. Reed, deputy editor for Commercial and R&D, got his first real job in journalism in 2000 with The Gray Sheet, then part of FDC Reports, based outside of Washington, DC, and has been covering medical technology ever since. His primary focus has been clinical trials and new product development, so he has covered innumerable FDA advisory panel meetings and Medicare coverage decisions. Mixed in to his many years with The Gray Sheet, Reed spent a year in Massachusetts with HCPro in that company’s pharma compliance editorial group, and three years as a reporter for theheart.org, when it was the best news source for cardiologists. In 2015, he became deputy editor of Medtech Insight, continuing to track the bewildering and rapidly evolving universe of new medical technology, from IVDs to artificial hearts, from pre-clinical trials to commercialization. Reed has a BA in religion from the College of William & Mary and an MA in Philosophy of Religion from Boston University. He lives and works in his hometown of State College, Pennsylvania.

Read more »


Amanda Maxwell

EU/ASIA

Amanda.Maxwell@informa.com

@MedtechAmanda

Amanda has over 30 years’ experience in reporting and providing analysis on developments in the field of medical technology regulatory affairs, with particular focus on the current and future EU regulations for medical device, IVDs and device/drug combination products.

Amanda closely monitors the implementation of the Medical Device and IVD Regulations and the challenges that the sector is encountering is being in compliance in time. In so doing, she keeps in constant communication with a broad base of expert contacts around Europe.

Moreover, as the UK heads for Brexit, she monitors the likely impact of political developments on the medtech sector.

Amanda also has experience in providing medtech regulatory strategy consultancy services, and is a frequently invited speaker and chair at EU meetings on medtech regulations and drug/device combination regulatory issues.

Read more »


Marion Webb

US

Marion.Webb@informa.com

@medtechMarion

Marion Webb, managing editor of Commercial, covers the in-depth Market Intelligence features, highlighting industry trends, the competitive landscape and emerging technologies with key insights from leading experts. She enjoys reporting live from industry events, tweeting breaking news and interviewing KOLs to provide high quality, business-critical content for Medtech Insight. Marion has been writing about health care issues for more than two decades. She was a long-time biotech reporter at the San Diego Business Journal, worked at Bloomberg News, and contributed to the Los Angeles County Medical Association’s Physician Magazine. She remains fascinated by the ever-growing numbers of innovative products coming out of the medtech sectors, which she covers in her in-depth Market Intelligence features. Marion earned her BA in communications from UC San Diego and lives in San Diego. She is an avid triathlete, proving that her passion for health issues extends far beyond her work at Medtech Insight

Read more »


Sue Darcey

Sue Darcey

US

Sue.Darcey@informa.com

Sue is a senior reporter covering the medical device and diagnostics industry. Her current fields of expertise and interest include monitoring medical device post market performance and safety, keeping tabs on US federal legislation and industry lobbying of Congress impacting medtech and diagnostics, covering US Medicare and Medicaid Services device reimbursement strategies, and writing about new genomic diagnostics and laboratory developed tests. A Washington DC-based trade journalist with over 30 years' experience covering Capitol Hill and regulatory agencies including FDA, CMS and the EPA, Sue is constantly on the look-out for any new laws, regulations, challenging device and test makers, and ways that firms resolve those issues. She also writes extensively about CMS changes to paying providers for their value-based practices, rather than on a fee-for-service basis, and how the changes affect device reimbursements.

When Sue is not covering the US Congress, CMS, and the medtech industry, she likes to be outdoors, where she can be found birding, hiking, gardening, swimming, and taking photos of flora and fauna of the US mid-Atlantic region.

Read more »


Danny AlFaruque

Ferdous Al-Faruque

US

Danny.Al-Faruque@informa.com

@alfaruque

Ferdous Al-Faruque, known as Danny, specializes in reporting on new medical device technologies such as mobile health, combination products, unique device identifiers, and issues surrounding interoperability and cybersecurity. He is also our resident podcast expert, and has brought listeners the voices of top FDA officials as well as industry leaders. Prior to joining Informa, Danny covered healthcare policy, politics and a number of other beats for news organizations such as The Hill newspaper, Time Magazine, ABC News, and more. He is well-traveled having grown up in places such as Bangladesh, Sweden and Poland which means he speaks multiple languages. Danny is also a big sci-fi fan, especially shows such as Battlestar Galactica and Star Trek. Qapla'!

Read more »


Elizabeth Orr

Elizabeth Orr

US

Elizabeth.Orr@informa.com

@elizabethjorr

Elizabeth reports on the medical device and diagnostics industry for Medtech Insight. She focuses on legal issues such as enforcement and intellectual property, but also covers device policy and regulation in the US and abroad. Elizabeth decided to be a reporter after watching Lois Lane in the Superman movies, and she's never looked back. After graduating from the University of Maryland's acclaimed College of Journalism, she began writing for the healthcare industry as a reporter/editor in DecisionHealth's home health newsletter division. She then worked for employers including the Society of Interventional Radiologists and the Washington Examiner before landing at FDA News, where she wrote and edited Devices & Diagnostics Letter for three years before moving to Informa in 2015. She lives in Arlington, Va., with her kids and her own personal Clark Kent.

Read more »


Catherine Longworth

EU/ASIA

Catherine.Longworth@informa.com

@MedtechCate

Catherine writes breaking news, features and analysis on commercial and R&D developments in the medical device industry, with a focus on Europe and Asia. She conducts exclusive interviews with the sector's biggest companies and experts, as well as innovative start-ups. Catherine Longworth is a business reporter for Medtech Insight covering the latest innovation and commercial news. Since joining Informa, she has reported across the world on emerging markets, new technologies and challenges facing the industry. Her specialist areas include digital health, machine learning, artificial intelligence, robotics, wearables and women's health.

Read more »


Ashley Yeo

EU/ASIA

Ashley.Yeo@informa.com

@ashleypyeo

Ashley Yeo delivers content that gives insight into current and future trends in the global medtech industry, and what players need to do, and with whom, to keep ahead of the game in this fast-evolving and highly competitive sector. He currently writes for In Vivo and Medtech Insight as an Executive Editor. Ashley has been with Informa and legacy publications, reporting on all forms of healthcare (plant, animal, human) for over 30 years, having joined as a linguist on the European desk and later becoming editor of three diverse publications. He has also contributed aesthetic medicine and pharma content when a member of the multifunctional team of pharma analysts. His current focus is the strategic rationale of the big players in medtech, on In Vivo; and UK, European and OUS global regulation and policy input on Medtech Insight.

Read more »


Maureen Kenny

EU/ASIA

Maureen.Kenny@informa.com

@ScripRegMaureen

Maureen brings exclusive, business-critical content to the Pink Sheet audience, building upon her many years' experience as an editor and reporter on pharmaceutical industry matters. She manages a team of experts who specialize in European and rest-of-world regulatory affairs. Maureen has had a wide and varied career at Informa, with previous leadership roles including editor of Scrip Regulatory Affairs before its amalgamation into the Pink Sheet. Previous leadership roles also include being editor of Clinica Medtech Intelligence and acting editor of Scrip Intelligence. Maureen spent two years in New York covering the pharmaceutical industry for Scrip Intelligence in the US, Canada and, being a fluent Spanish speaker, Latin America. Past accomplishments include chairing the DIA EuroMeeting plenary session in Paris in April 2015. Maureen is based in London. Maureen specializes in European regulatory affairs, with a current focus on the European Medicines Agency and the broader EU pharmaceutical regulatory network. Brexit is already having a massive impact regulators on the industry and covering developments in these areas is a major current focus.

Read more »


Neena Brizmohun

Neena Brizmohun

EU/ASIA

Neena.Brizmohun@informa.com

@ScripRegNeena

Neena has over 20 years of experience covering regulatory, business and market access developments impacting pharmaceutical and medical device companies.

She explores the challenges and opportunities that developments worldwide introduce for industry and regulators. Her areas of expertise include regulatory schemes for getting products to market faster. Neena's other specialist areas include new medicines coming to market in the EU, clinical trials, post-marketing safety monitoring, transparency policies relating to the publication of trial data, and global harmonization initiatives for pharma and medtech.

A scientist by training, Neena started her journalistic career at Informa in 1997. Before becoming a journalist she worked as a biomedical scientist at St Thomas' Hospital in London for 10 years.

Read more »


Vibha Sharma

Vibha Sharma

EU/ASIA

Vibha.Sharma@informa.com

@ScripRegVibha

Vibha Sharma is a senior reporter covering pharmaceutical and medtech regulatory developments across the globe. She plays a key role in tracking and writing about news of important regulatory issues affecting the sectors, and explaining their implications for industry. Vibha's fields of interest include the EU Pharmacovigilance legislation and the EU Pediatrics Regulation on which she has written several exclusive articles from various industry conferences. She has also commissioned some pieces of expert analysis on major developments in the pharma and medtech regulatory arenas.
Before joining Informa, she was principal correspondent with India's national newspaper Hindustan Times, where she reported on health and medical issues, besides several other topics. She has also worked with two other Indian national dailies, The Indian Express and The Asian Age.

Read more »


Richard Faint

EU/ASIA

Richard.Faint@informa.com

Dr Richard Faint is Head of Content, leading the medical device and diagnostics, and consumer health teams, who together bring diverse clinical, commercial, and regulatory experience to deliver clear and innovative business solutions to clients. Richard has clinical and commercial experience gained from hospital practice, the pharmaceutical industry, and working with market research and consultancy firms. Richard joined Informa via Datamonitor Ltd in 2003 as the Director of Oncology Analysis, and then as Director of Therapy Analysis. Richard creates and delivers successful business products and services using financial and clinical data, epidemiology, electronic medical records and primary research.

Before joining Datamonitor and Informa, Richard worked in different roles for over 10 years for a UK biophamaceutical company specializing in the discovery and development of novel molecules targeting cancer. Richard has experience in laboratory and developmental diagnostics, in cancer chemotherapy, using targeted therapies in angiogenesis and metastases, as well as immunology and cardiovascular disease. With an MBA (OUBS) and a PhD in cell signalling mechanisms (UCL), Richard is excited by the scientific and clinical advances that continue to deliver deeper understanding and new treatments for life-threatening diseases.

 
UsernamePublicRestriction

Register